Related references
Note: Only part of the references are listed.The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
How tumors might withstand γδ T-cell attack
Aude-Helene Capietto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Immunotherapy for Ovarian Cancer: What's Next?
Lana E. Kandalaft et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients
Florian Cabillic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Targeting γδ T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application
Anita Q. Gomes et al.
CANCER RESEARCH (2010)
Impact of age, gender, and race on circulating γδ T cells
Cristiana Cairo et al.
HUMAN IMMUNOLOGY (2010)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells
Volker Kunzmann et al.
IMMUNOLOGY (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Bridging innate and adaptive immunity through γδ T-dendritic cell crosstalk
Emmanuel Scotet et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
Emilie Viey et al.
JOURNAL OF IMMUNOTHERAPY (2008)
V gamma 9V delta 2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas
Francoise Bouet-Toussaint et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma
Maka Burjanadze et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Large scale expansion of γ9δ2 T lymphocytes:: Innacell γδTM cell therapy product
Samuel Salot et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Self/non-self discrimination by human γδ T cells:: simple solutions for a complex issue?
Aurelie Thedrez et al.
IMMUNOLOGICAL REVIEWS (2007)
Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
Marc Bonneville et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Sex-specific phenotypical and functional differences in peripheral human Vγ9/Vδ2 T cells
Nadia Caccamo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the ceff-surface receptor CRTAM
KS Boles et al.
BLOOD (2005)
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
MR Raspollini et al.
ANNALS OF ONCOLOGY (2005)
Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites
M Bonneville et al.
MICROBES AND INFECTION (2005)
Homing and memory patterns of human γδ T cells in physiopathological situations
L Battistini et al.
MICROBES AND INFECTION (2005)
Tcr ζ-chain downregulation:: Curtailing an excessive inflammatory immune response
M Baniyash
NATURE REVIEWS IMMUNOLOGY (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
